(Q50852969)

24 March 2018

title

Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. (English)

1 reference

24 March 2018

amyotrophic lateral sclerosis

main subject

1 reference

C Armon

1

1 reference

24 March 2018

D Moses

series ordinal

2

1 reference

24 March 2018

publication date

1 October 1998

1 reference

24 March 2018

Journal of the Neurological Sciences

published in

1 reference

24 March 2018

volume

160 Suppl 1

1 reference

24 March 2018

page(s)

S37-41

1 reference

24 March 2018

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900196-8

Recombinant growth hormone treatment of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900196-8

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900196-8

Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900196-8

10.1016/S0022-510X(98)00196-8

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

9851647

1 reference

24 March 2018